BPMC
$79.45
Blueprint Medicines
$1.11
1.42%
BPMC
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  $6.43
Revenue:  $548.41 Mil
Thursday
Oct 29
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BPMC reports earnings?
Beat
Meet
Miss

Where is BPMC's stock price going from here?
Up
Flat
Down
Stock chart of BPMC
Analysts
Summary of analysts' recommendations for BPMC
Score
Grade
Pivots
Resistance
$82.90
$81.39
$80.42

$78.92

Support
$77.95
$76.44
$75.47
Tweet
Growth
Description
Blueprint Medicines Corp is an oncology company which is engaged in developing kinase inhibitors for genomically defined cancer subsets. Blueprint Medicines Corp is based in Cambridge, MA.